BR0012301A - Inibidores de crescimento de células epiteliais - Google Patents

Inibidores de crescimento de células epiteliais

Info

Publication number
BR0012301A
BR0012301A BR0012301-3A BR0012301A BR0012301A BR 0012301 A BR0012301 A BR 0012301A BR 0012301 A BR0012301 A BR 0012301A BR 0012301 A BR0012301 A BR 0012301A
Authority
BR
Brazil
Prior art keywords
epithelial cell
cell growth
growth inhibitors
epithelial
ecgi
Prior art date
Application number
BR0012301-3A
Other languages
English (en)
Inventor
Raul R Ervin Jr
Original Assignee
Biotherapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotherapies Inc filed Critical Biotherapies Inc
Publication of BR0012301A publication Critical patent/BR0012301A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "INIBIDORES DE CRESCIMENTO DE CéLULAS EPITELIAIS". Os inibidores de crescimento de células epiteliais diferencialmente expressam em células epiteliais cancerosas e normais. As proteínas ECGI e sequência de ácido nucleico codificando as mesmas são utilizáveis no diagnóstico e tratamento de cânceres de células epiteliais, por exemplo próstata, ovariano, câncer do cólon e outros.
BR0012301-3A 1999-06-18 2000-06-19 Inibidores de crescimento de células epiteliais BR0012301A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13999599P 1999-06-18 1999-06-18
PCT/US2000/016900 WO2000078955A1 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Publications (1)

Publication Number Publication Date
BR0012301A true BR0012301A (pt) 2002-03-26

Family

ID=22489251

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012301-3A BR0012301A (pt) 1999-06-18 2000-06-19 Inibidores de crescimento de células epiteliais

Country Status (13)

Country Link
EP (1) EP1190054A1 (pt)
JP (1) JP2003513615A (pt)
KR (1) KR20020016837A (pt)
CN (1) CN1399680A (pt)
AU (1) AU783373B2 (pt)
BR (1) BR0012301A (pt)
CA (1) CA2375498A1 (pt)
IL (1) IL147148A0 (pt)
MX (1) MXPA01013242A (pt)
NZ (1) NZ516545A (pt)
PL (1) PL352997A1 (pt)
WO (1) WO2000078955A1 (pt)
ZA (1) ZA200200145B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
AU2000257514A1 (en) * 2000-06-19 2002-01-02 The University Of Michigan Mammastatin sequence variant c
CN102787094B (zh) * 2011-05-17 2015-09-23 李晖 培养基、细胞培养用试剂盒及细胞培养方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
WO1998014577A2 (en) * 1996-10-03 1998-04-09 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor

Also Published As

Publication number Publication date
KR20020016837A (ko) 2002-03-06
AU6052300A (en) 2001-01-09
NZ516545A (en) 2004-06-25
IL147148A0 (en) 2002-08-14
MXPA01013242A (es) 2002-11-04
WO2000078955A1 (en) 2000-12-28
EP1190054A1 (en) 2002-03-27
JP2003513615A (ja) 2003-04-15
ZA200200145B (en) 2003-04-30
CA2375498A1 (en) 2000-12-28
AU783373B2 (en) 2005-10-20
WO2000078955A9 (en) 2002-09-06
PL352997A1 (en) 2003-09-22
CN1399680A (zh) 2003-02-26

Similar Documents

Publication Publication Date Title
TR199701462T1 (xx) DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini.
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
WO2003004989A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DK1112275T3 (da) Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
WO2002071928A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
ATE402188T1 (de) Bindungsproteine als biosensoren
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
HUP0402656A2 (hu) Sejtterápiás eljárás tumorok kezelésére
DE69837754D1 (de) Kombinierte tumor suppressor-gen-therapie und chemotherapie bei der neoplasmabehandlung
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
ATE350662T1 (de) Markerproteine für prostatakrebs
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
BR0012301A (pt) Inibidores de crescimento de células epiteliais
NZ516237A (en) Meth1 and meth2 polynucleotides and polypeptides

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.